Abstract
Three drugs continue to be under intensive clinical assessment to determine whether they can reduce mortality and morbidity following thrombo-occlusive cerebro-vascular or cardiovascular accidents. These drugs are aspirin, dipyridamole and sulphinpyrazone. The most recent trials to be completed are those relating to sulphinpyrazone (Anturane Reinfarction Trial Research Group, 1980), aspirin (Aspirin Myocardial Infarction Study Research Group, 1980) and aspirin alone or in combination with dipyridamole (Persantine-Aspirin Reinfarction Study Research Group, 1980). None of these drugs were invented for use after stroke or myocardial infarction and much effort has gone into their investigation in animal models thought to have some bearing on the development or the consequences of vessel disease in man. In this review attention will be paid to data derived from in vivo animal models in which either thrombus formation and changes in the intima and media of the vasculature occur as a result of direct injury to the endothelium, or in which platelet aggregation follows from the administration of a known platelet agonist. For the most part discussion of the effect of these drugs on the heart will derive from variants of the well-known coronary ligation models.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adams, J. H. & Mitchell, J. R. A. (1979). The effect of agents which modify platelet behaviour and magnesium ions on thrombus formation in vivo. Thromb. Haemost., 42, 603–610.
Anturane Reinfarction Trial Research Group (1980). Sulfinpyrazone in the prevention of sudden death after myocardial infarction. New Eng. J. Med., 302, 250–256.
Arfors, K.-E., Hint, H. C., Dhall, D. P. & Methson, N. A. (1968). Counteraction of platelet activity at sites of laser-induced endothelial trauma. Brit. med. J., 4, 430–431.
Aspirin Myocardial Infarction Study Research Group (1980). A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. J. Am. med. Ass., 243, 661–669.
Barth, P., Zimmerman, R., Zieboll, J. & Lange, D. (1975). The anti-thrombotic effect of acetylsalicylic acid, heparin and phenprocoumon in experimental thrombosis. Thromb. Diath. Haemorrh. (Stuttg.), 34, 554–555.
Baumgartner, H. R. & Studer, A. (1976). Platelet factors and the proliferation of vascular smooth muscle cells. In Atherosclerosis. IV. Proc. 4th International Symposium of Atherosclerosis, Tokyo, 1976. Berlin: Springer.
Begent, N. & Born, G. V. R. (1970). Growth rate in vivo of platelet thrombi produced by iontophoresis of ADP, as a function of mean flow velocity. Nature, 227, 926–930.
Berman, H. F. (1961). Anticoagulant-induced alterations in haemostasis, platelet thrombosis and vascular fragility in the peripheral vessels of the hamster cheek pouch. In Anticoagulants and Fibrinolysis, ed. McMillan, R. L. & Mustard, J. F. pp. 95–107. Pitman Medical, U.K./Macmillan, Toronto.
Born, G. V. R., Honour, A. J. & Mitchell, J. R. A. (1964). Inhibition by adenosine and 2 chloro-adenosine of the formation and embolisation of platelet thrombi. Nature, 202, 761–765.
Brunner, L., Stepanek, J. & Brunner, H. (1980). Reduction of mortality by sulphinpyrazone after experimental myocardial infarction in the rat. J. Pharm. Pharmac., in press.
Buchanan, M. R., Rosenfeld, J. & Hirsh, J. (1978). The prolonged effect of sulfinpyrazone on collagen-induced platelet aggregation in vivo. Thromb. Res., 13, 883–892.
Buchanan, M. R. & Hirsh, J. (1978). A comparison of the effects of aspirin and dipyridamole on platelet aggregation in vivo and ex vivo. Thromb. Res., 13, 517–529.
Bunag, R. D., Douglas, C. R., Imai, S. & Berne, R. M. (1964). Influence of a pyrimidopyrimidine derivative on deamination of adenosine by blood. Circulation Res., 15, 83–88.
Burns, J. J., Yu, T. F., Ritterbrand, A., Perel, J. M. & Gutman, B. A. (1957). A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue G 25671. J. Pharmac. exp. Ther., 119, 418–426.
Butler, K. D., Pay, G. F., Roberts, J. M. & White, A. M. (1979). The effect of sulphinpyrazone and other drugs on the platelet response during the acute phase of the active Arthus reaction in guinea pigs. Thromb. Res., 15, 319–340.
Butler, K. D., Wallis, R. B. & White, A. M. (1979). A study of the relationship between ex vivo and in vivo effects of sulphinpyrazone in the guinea pig. Haemostasis, 8, 353–360.
Butler, K. D., Dieterle, W., Maguire, E. D., Pay, G. F., Wallis, R. B. & White, A. M. (1980). Sustained effects of sulphinpyrazone. In Cardiovascular Actions of Sulphinpyrazone: Basic and Clinical Research, ed. McGregor, M., Mustard, J. F., Oliver, M. F. & Sherry, S. pp. 19–34. Miami: Symposia Specialists Inc.
Butler, K. D. & White, A. M. (1980). Inhibition of platelet involvement in the sublethal Forssman reaction by sulphinpyrazone. In Cardiovascular Actions of Sulphinpyrazone: Basic and Clinical Research, ed. McGregor, M, Mustard, J. F., Oliver, M. F. & Sherry, S. pp. 3–15. Miami: Symposia Specialists Inc.
Cairncross, K. D., Bassett, J. R. & Martin, C. (1979). The effect of sulfinpyrazone on morphological changes in the coronary vasculature induced by prolonged unpredictable stress in the rat. Pharmac. Biochem. Behav., 10, 285–291.
Clopath, P., Horsch, A. K. & Dieterle, W. (1980). Effects of sulfinpyrazone in development of atherosclerosis in various animal models. In Cardiovascular Actions of Sulphinpyrazone: Basic and Clinical Research, ed. McGregor, M., Mustard, J. F., Oliver, M. F. & Sherry, S. pp. 121–137. Miami: Symposia Specialists Inc.
Clowes, A. W. & Karnovsky, M. J. (1977). Failure of certain anti-platelet drugs to affect myointimal thickening following arterial endothelial injury in the rat. Lab. Invest., 36, 452–464.
Danese, C. A., Voleti, C. H. D. & Weiss, H. J. (1971). Protection by aspirin against experimentally induced arterial thrombosis in dogs. Thromb. Diath. Haemorrh. (Stuttg.), 25, 288–296.
Davenport, N., Goldstein, R. E. & Capurro, N. L. (1979). Sulfinpyrazone increases collateral blood flow following acute coronary occlusion. Am. J. Cardiol., 43, 396.
Didisheim, P. (1968). Inhibition by dipyridamole of arterial thrombosis in rats. Thromb. Diath. Haemorrh. (Stuttg.), 20, 257–266.
Emmons, P. R., Harrison, M. J. G., Honour, A. J. & Mitchell, J. R. A. (1965). Effect of dipyridamole on human platelet behaviour. Lancet, 2, 603–606.
Emmons, P. R. & Mitchell, J. R. A. (1965). Postoperative changes in platelet-clumping activity. Lancet, 1, 71–75.
Evans, G. O. & Mustard, J. F. (1968). Inhibition of the platelet surface reaction in endotoxic shock and the generalised Schwartzman reaction. J. clin. Invest., 47, 31A.
Folts, J. D. & Beck, R. A. (1980). Inhibition of platelet plugging in stenosed dog coronary arteries with sulfinpyrazone. In Cardiovascular Actions of Sulphinpyrazone: Basic and Clinical Research, ed. McGregor, M., Mustard, J. F., Oliver, M. F. & Sherry, S. pp. 211–225. Miami: Symposia Specialists Inc.
Haarman, W. & Kadatz, R. (1975). Effect of dipyridamole on blood platelets in pharmacological experiments. Acta clin. Belg., 30, 190–194.
Haft, J. I., Gershengorm, K., Kranz, P. D. & Oestreicher, R. (1972). Protection against epinephrine-induced myocardial necrosis by drugs that inhibit platelet aggregation. Am. J. Cardiol., 30, 838–843.
Harker, L. A., Ross, R., Slichter, S. J. & Scott, C. R. (1976). Homocysteine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J. clin. Invest., 58, 731–741.
Harker, L. A., Wall, R. T., Harlan, J. M. & Ross, R. (1979). Sulfinpyrazone prevention of homocysteine-induced endothelial cell injury. Clin. Res., 24, 554A.
Hladovec, J. (1975). The effect of some anti-thrombotic drugs on experimental arterial thrombosis. Cor. Vasa., 17, 66–74.
Holmes, F. A., Smith, G. M. & Freuler, F. (1977). The effect of intravenous adenosine diphosphate on the number of circulating platelets in experimental animals. Thromb. Haemost., 37, 36–46.
Honour, A. J. & Ross-Russell, R. W. (1962). Experimental platelet embolism. Brit. J. exp. Path., 43, 350–362.
Honour, A. J. & Mitchell, J. R. A. (1964). Platelet clumping in injured vessels. Brit. J. exp. Path., 45, 75–87.
Kelliher, G. F., Dix, R. K., Jurkiewicz, N. & Lawrence, M. D. (1980). Effect of sulfinpyrazone on arrythmia and death following coronary occlusion in cats. In Cardiovascular Actions of Sulphinpyrazone: Basic and Clinical Research, ed. McGregor, M., Mustard, J. F., Oliver, M. F. & Sherry, S. pp. 193–207.Miami: Symposia Specialists Inc.
Kelton, J. G., Hirsh, J., Carter, C. J. & Buchanan, M. R. (1978). Thrombogenic effect of high dose aspirin in rabbits. J. clin. Invest., 62, 892–895.
Jamieson, S. W., Burton, N. A. & Reitz, B. A. (1980). Platelets sulfinpyrazone and organ graft rejection. In Cardiovascular Actions of Sulfinpyrazone: Basic and Clinical Research. ed. McGregor, M., Mustard, J. F., Oliver, M. F. & Sherry, S. pp. 229–243. Miami: Symposia Specialists Inc.
Lewis, G. P. & Westwick, J. (1977). An in vivo model for studying arterial thrombosis. In Thromboembolism — A New Approach to Therapy, ed. Mitchell, J. R. A. & Domenet, J. G. pp. 40–54. London: Academic Press.
Macdonald, A., Busch, G. J., Alexander, J. L., Pheteplace, E. A., Menzoian, J. & Murray, J. E. (1969). Heparin and aspirin in the treatment of hyperacute rejection of renal allografts in presensitised dogs. Trans., 9, 1–7.
Maguire, E. D., Pay, G. F., Turney, J., Wallis, R. B., Weston, M. J., White, A. M, Williams, L. S. & Woods, H. (1980). The effects of two different dosage regimens of sulphinpyrazone on platelet function ex vivo and blood chemistry in man. Haemostasis, in press.
Mathew, T. H., Hogan, G. P., Lewers, D. T., Bauer, H., Maher, J. F. & Schremer, G. E. (1971). Controlled double-blind trial of anti-platelet aggregating agents in vascular renal allograft rejection. Transplantation Proc., 3, 901–904.
Mayer, J. E. & Hammond, G. L. (1973). Dipyridamole and aspirin tested against an experimental model of thrombosis. Ann. Surg., 178, 108–112.
Meng, K. & Seuter, F. (1977). Effect of salicylic acid on experimentally-induced arterial thrombosis in rats. Naunyn-Schmiedebergs Arch. Pharmac., 301, 115–119.
Moore, S. & Ihnatowycz, I. O. (1978). Vessel injury and atherosclerosis. In Thrombosis: Animals and Clinical Models, ed. Day, H. J., Maloney, B. O., Ishizawa, E. E. & Rynbrandt, R. H. New York: Plenum.
Moschos, C. B., Zahiri, K., Lyons, M., Weiss, A. B., Oldewurtel, H. A., Regan, T. J. & Newark, N. J. (1973). Relation of microcirculatory thrombosis to thrombus in the proximal coronary artery: effect of aspirin, dipyridamole and thrombolysis. Am. Heart J., 86, 61–68.
Moschos, C. B., Haider, B., Khan, Y., Lyons, M. M. & Regan, T. (1978). Relation of platelets to catecholamine-induced myocardial injury. Cardiovas. Res., 12, 243–246.
Moschos, C. B., Escobinas, A. J. & Jorgensen, O. B. (1979. Effect of sulfinpyrazone on survival following experimental non-thrombogenic coronary occlusion. Am. J. Cardiol., 43, 372.
Moschos, C. B., Escobinas, A. J. & Jorgensen, O. B. (1980). Effects of sulfinpyrazone on ischaemic myocardium. In Cardiovascular Actions of Sulfinpyrazone: Basic and Clinical Research, ed. McGregor, M., Mustard, J. F., Oliver, M. F. & Sherry, S. pp. 175–187. Miami: Symposia Specialists Inc.
Müller, K. R. (1980). Lack of protective effect of sulfinpyrazone on endothelial cells from pig aorta in culture. In Cardiovascular Actions of Sulfinpyrazone: Basic and Clinical Research. ed. McGregor, M., Mustard, J. F., Oliver, M. F. & Sherry, S. pp. 113–120. Miami: Symposia Specialists Inc.
Pedersen, A. K. & Jakobsen, P. (1979). Two new metabolites of sulphinpyrazone in the rabbit: A possible cause of the prolonged in vivo effect. Thromb. Res., 16, 871–876.
Persantine-Aspirin Reinfarction Study Research Group. (1980). Circulation, in press.
Peterson, J. & Zucker, M. B. (1970). The effect of adenosine monophosphate, arcaine and antiinflammatory agents on thrombosis and platelet function in rabbits. Thromb. Diath. Haemorrh. (Stuttg.), 23, 148–158.
Pick, R., Chediak, J. & Glick, G. (1979). Aspirin inhibits development of coronary atherosclerosis in Cymomolgens monkeys (Macaca Fascicularis) fed an atherogenic diet. J. clin. Invest., 63, 158–162.
Povalski, H. J., Olson, R., Koria, S. & Furness, P. (1980). Comparative effects of sulfinpyrazone and aspirin in the coronary occlusion — reperfusion dog model. In Cardiovascular Actions of Sulfinpyrazone: Basic and Clinical Research. ed. McGregor, M., Mustard, J. F., Oliver, M. F. & Sherry, S. pp. 153–177. Miami: Symposia Specialists Inc.
Renaud, S. & Lecompte, F. (1970). Thrombosis prevention by coagulation and platelet aggregation inhibitors in hyperlipaemic rats. Thromb. Diath. Haemorrh. (Stuttg.), 24, 577–586.
Roberts, A. J., Jacobstein, J. G., Cipriano, P. R., Alonso, D. R., Combes, J. R. & Gay, W. A. (1980). Effectiveness of dipyridamole in reducing the size of experimental myocardial infarction. Circulation, 61, 228–236.
Sharma, H. M., Moore, S., Merrick, H. W. & Smith, M. R. (1972). Platelets in early hyperacute allograft rejection in kidneys and their modification by sulfinpyrazone therapy. Am. J. Path., 66, 445–460.
Sharma, H. M., Rosensweig, J., Chatterjee, S., Moore, S. & de Champlain, M.-L. (1973). Platelets in hyperacute rejection of heterotopic cardiac allografts in presensitized dogs. Am. J. Path., 70, 155–174.
Sullivan, J. M., Harken, D. E. & Goslin, R. (1971). Pharmacologic control of thromboembolic complications of cardiac valve replacement. New Eng. J. Med., 284, 1391–1394.
Vaessen, L. M. B., Benthuis, F., Hesse, C. J. & Lameizer, L. D. F. (1977). Effect of sulfinpyrazone (Anturane) in man. Eur. J. clin. Pharmac., 9, 135–145.
Author information
Authors and Affiliations
Editor information
Copyright information
© 1980 The contributors
About this chapter
Cite this chapter
White, A.M., Butler, K.D. (1980). The Effect of Platelet Regulatory Drugs in Experimental Models of Thrombosis, Atherosclerosis and Myocardial Ischaemia. In: Turner, P., Padgham, C., Hedges, A. (eds) Clinical Pharmacology & Therapeutics. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-05952-2_22
Download citation
DOI: https://doi.org/10.1007/978-1-349-05952-2_22
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-05954-6
Online ISBN: 978-1-349-05952-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)